Neo Cremar Co., Ltd.
Financials
Valuation Metrics
Neo Cremar Co., Ltd.'s Market Cap is ₩275B. At end of 2025 it was ₩743B. Ranked #2080 of 2,411 in KR market (top 86%), #1333 of 1,632 on KOSDAQ (top 82%), #69 of 82 in Food, Beverage & Tobacco (top 84%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 27.46B KRW | KR#2,080/2,411 Sec#69/82 |
| Revenue | 81.63B KRW | KR#1,542/2,411 Sec#69/82 |
| Net Income | 7.31B KRW | KR#1,078/2,411 Sec#41/82 |
| Total Assets | 189.37B KRW | KR#1,351/2,411 Sec#60/82 |
| Net Assets | 149.96B KRW | KR#1,133/2,411 Sec#49/82 |
| Employees | 69 | KR#1,883/2,411 Sec#69/82 |
| Value | ||
| P/E | 3.76x | KR#272/2,411 Sec#17/82 |
| P/B | 0.18x | KR#135/2,411 Sec#9/82 |
| PEG | 0.02x | KR#197/2,411 Sec#10/82 |
| P/S | 0.34x | KR#725/2,411 Sec#57/82 |
| EV/EBITDA | 5.61x | KR#334/2,411 Sec#17/82 |
| FCF Yield | 54.50% | KR#82/2,411 Sec#8/82 |
| Profitability | ||
| ROE | 4.87% | KR#1,114/2,411 Sec#36/82 |
| ROA | 3.86% | KR#901/2,411 Sec#26/82 |
| Op. Margin | 4.38% | KR#1,042/2,411 Sec#38/82 |
| Revenue Growth | 15.14% | KR#677/2,411 Sec#8/82 |
| Earnings Growth | 188.19% | KR#257/2,411 Sec#10/82 |
| Financial Health | ||
| Debt Ratio | 26.28% | KR#505/2,411 Sec#10/82 |
| Total Debt | 12.88B KRW | KR#1,539/2,411 Sec#68/82 |
| FCF | 14.97B KRW | KR#600/2,411 Sec#39/82 |
| Cash | 20.25B KRW | KR#1,244/2,411 Sec#52/82 |
| Current Ratio | 4.55x | KR#321/2,411 Sec#2/82 |
| Net Debt/EBITDA | -2.06x | KR#230/2,411 Sec#3/82 |
| Dividend | ||
| Div. Yield | 2.24% | KR#869/2,411 Sec#49/82 |
| Performance | ||
| 1Y Return | -70.83% | KR#2,275/2,411 Sec#79/82 |
| 1M Return | -12.85% | KR#1,610/2,411 Sec#75/82 |
| From 52W High | -72.53% | KR#2,160/2,411 Sec#77/82 |
| 1Y MDD | -71.26% | KR#2,055/2,411 Sec#77/82 |
| Trading | ||
| Volume | 7,302 shares | KR#2,029/2,411 Sec#61/82 |
| Trading Value | 15.7M KRW | KR#2,189/2,411 Sec#76/82 |
| Foreign Own. | 3.59% | KR#1,137/2,411 Sec#40/82 |
| Per Share | ||
| EPS | 578 KRW | KR#938/2,411 Sec#39/82 |
| BPS | 11,851 KRW | KR#866/2,411 Sec#46/82 |
Company Info
Established in 2007 with functional sugar and peptide product manufacturing and product distribution as its main businesses, the company was listed on KOSDAQ in 2019. Through its main subsidiary, BBC Co., Ltd., it operates material businesses such as monofilament and functional air filters, and healthcare businesses including toothbrushes. As a microbiome-based functional food material company, it produces galactooligosaccharides and low molecular weight yeast peptides, leading the market by globally launching organic galactooligosaccharides for the first time. Neocrema was established in 2007 and is headquartered in Gangnam-gu, Seoul.